Alpinder Grewal - CareRx Corp Senior Transformation
| CRRX Stock | CAD 1.89 0.01 0.53% |
Executive
Alpinder Grewal is Senior Transformation of CareRx Corp
| Address | 320 Bay Street, Toronto, ON, Canada, M5H 4A6 |
| Phone | 416 927 8400 |
| Web | https://www.carerx.ca |
CareRx Corp Management Efficiency
The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.075) %, meaning that it generated substantial loss on money invested by shareholders. CareRx Corp's management efficiency ratios could be used to measure how well CareRx Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to drop to 0.03. As of the 29th of November 2024, Debt To Assets is likely to grow to 0.41, while Total Assets are likely to drop about 178.4 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Mudit Garg | D2L Inc | N/A | |
| Mark Waddell | Baylin Technologies | N/A | |
| Melissa Howatson | D2L Inc | 50 | |
| Christian Pantel | D2L Inc | N/A | |
| Al Patel | D2L Inc | N/A | |
| Anna Forgione | D2L Inc | 59 | |
| Puneet Arora | D2L Inc | 49 | |
| Amy Clark | D2L Inc | N/A | |
| Alys Scott | D2L Inc | 57 | |
| Jeremy Auger | D2L Inc | N/A | |
| Shaul Montgomery | Baylin Technologies | 54 | |
| Nick Oddson | D2L Inc | 50 | |
| Pierre Soulard | Baylin Technologies | 56 | |
| Laurent Pefferkorn | Velan Inc | N/A | |
| Denis Lee | Baylin Technologies | 50 | |
| Tony Radford | Baylin Technologies | N/A | |
| Philip Mohtadi | Baylin Technologies | N/A | |
| Tom Donnelly | D2L Inc | 62 | |
| Stephen Laster | D2L Inc | 59 | |
| Rajesh Talpade | D2L Inc | N/A | |
| Lee Poteck | D2L Inc | N/A | |
Management Performance
| Return On Equity | -0.075 | ||||
| Return On Asset | 0.0218 |
CareRx Corp Leadership Team
Elected by the shareholders, the CareRx Corp's board of directors comprises two types of representatives: CareRx Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CareRx. The board's role is to monitor CareRx Corp's management team and ensure that shareholders' interests are well served. CareRx Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CareRx Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Puneet Khanna, Chief Officer | ||
| Ryan Stempfle, VP Division | ||
| Davide Pernarella, Interim Officer | ||
| Adrianne Campeau, Chief Officer | ||
| Travis Featherstone, Senior Integration | ||
| Alpinder Grewal, Senior Transformation | ||
| David Murphy, CEO Pres | ||
| Andrew Mok, Chief Officer | ||
| Alvin Chau, Senior Technology | ||
| Paul Rakowski, General Development | ||
| Suzanne Brand, Chief Officer |
CareRx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CareRx Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.075 | ||||
| Return On Asset | 0.0218 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 199.59 M | ||||
| Shares Outstanding | 63.49 M | ||||
| Shares Owned By Insiders | 10.60 % | ||||
| Shares Owned By Institutions | 50.14 % | ||||
| Number Of Shares Shorted | 8.6 K | ||||
| Price To Book | 1.49 X |
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.